SCHEMBL1671206

SCHEMBL1671206

OCc1ccc(CC2Cc3ccccc3C23CCNCC3)cc1

nearest known ligand 0.39

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.38
MDM2 Q00987 1/20 0.38
SIGMAR1 Q99720 2/20 0.36
KDM1A O60341 4/20 0.36
MCHR2 Q969V1 2/20 0.35
HTR2A P28223 2/20 0.34
DRD2 P14416 1/20 0.34
SLC6A2 P23975 1/20 0.34
HTR2C P28335 1/20 0.34
SLC6A4 P31645 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6669198 0.78 SIGMAR1 (0.38) SIGMAR1KDM1AHTR2ADRD2SLC6A2
Hydrochloric Acid SCHEMBL6669828 0.72 HTR2A (0.36) SIGMAR1KDM1AHTR2ADRD2SLC6A2
SCHEMBL4975811 0.71 MCHR2 (0.46) SIGMAR1KDM1AMCHR2HTR2ADRD2
SCHEMBL30573675 0.71 MCHR2 (0.46) SIGMAR1KDM1AMCHR2HTR2ADRD2
Hydrochloric Acid SCHEMBL6668923 0.71 HTR2A (0.35) SIGMAR1KDM1AHTR2ADRD2SLC6A2
Hydrochloric Acid SCHEMBL6976186 0.70 MCHR2 (0.45) SIGMAR1KDM1AMCHR2HTR2ADRD2
Hydrochloric Acid SCHEMBL6973147 0.70 MCHR2 (0.45) SIGMAR1KDM1AMCHR2HTR2ADRD2
SCHEMBL21383813 0.70 KDM1A (0.53) SIGMAR1KDM1AHTR2ADRD2SLC6A2
SCHEMBL21920651 0.70 KDM1A (0.53) SIGMAR1KDM1AHTR2ADRD2SLC6A2
SCHEMBL29993139 0.70 KDM1A (0.53) SIGMAR1KDM1AHTR2ADRD2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488500-A1 SPIROPIPERIDINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF FOR TREATING DIABETES Eli Lilly and Company (US) 2012-08-22 EP disclosed
WO-2011046851-A1 SPIROPIPERIDINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF FOR TREATING DIABETES ELI LILLY AND COMPANY (US) 2011-04-21 WO disclosed